American Journal of Cardiology
Volume 102, Issue 9, Supplement , Pages 24J-28J , 3 November 2008

Drug-Eluting Stents in the Real World: How Intravascular Ultrasound Can Improve Clinical Outcome

References 

  1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–1780
  2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323
  3. Schampaert E, Cohen EA, Schlüter M, Reeves F, Traboulsi M, Title LM, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol. 2004;43:1110–1115
  4. Schofer J, Schlüter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS). Lancet. 2003;362:1093–1099
  5. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364:1519–1521
  6. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol. 2006;47:2108–2111
  7. Feres F, Costa JR, Abizaid A. Very late thrombosis after drug-eluting stents. Catheter Cardiovasc Interv. 2006;68:83–88
  8. Das P, Meredith I. Role of intravascular ultrasound in unprotected left main percutaneous coronary intervention. Expert Rev Cardiovasc Ther. 2007;5:81–89
  9. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, et al ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2005;113:156–175
  10. Dangas GD, Mehran R, Moses JW, et al. Long-term safety of drug eluting stents in off-label use: results of the MATRIX registry. Presented at the i2 American College of Cardiology 2007 Late-Breaking Trial Session; March 24–27 2007;New Orleans, Louisiana
  11. Airoldi F, Colombo A, Morici N, Latib A, Cosgrave J, Buellesfeld L, et al Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation. 2007;116:745–754
  12. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, et al Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007;297:159–168
  13. The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494–502
  14. Steinhubl SR, Berger PB, Mann JT, Fry ET, DeLago A, Wilmer C, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. JAMA. 2002;288:2411–2420
  15. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, et al Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706–1717
  16. The GUSTO Investigators. An International Trial comesring four Thrombolytic Strategies for Acute Myocardial Infarction. NEJM. 1994;329:673–682
  17. Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, et al Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol. 2007;49:1982–1988
  18. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, et al Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation. J Am Coll Cardiol. 2005;45:995–998
  19. Okabe T, Mintz GS, Buch AN, Roy P, Hong YJ, Smith KA, et al Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment. Am J Cardiol. 2007;100:615–620
  20. Sonoda S, Morino Y, Ako J, Terashima M, Hassan AH, Bonneau HN, et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation. J Am Coll Cardiol. 2004;43:1959–1963
  21. Hong MK, Mintz GS, Lee CW, Park DW, Choi BR, Park KH, et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J. 2006;27:1305–1310
  22. Sakurai R, Ako J, Morino Y, Sonoda S, Kaneda H, Terashima M, et al Predictors of edge stenosis following sirolimus-eluting stent deployment (a qualitative intravascular ultrasound analysis from the SIRIUS Trial). Am J Cardiol. 2005;96:1251–1253
  23. Kimura M, Mintz GS, Carlier S, Takebayashi H, Fujii K, Sano K, et al Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound. Am J Cardiol. 2006;98:436–442
  24. Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, et al Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation. 2006;113:414–419

 Statement of author disclosure: Please see the Author Disclosures section at the end of this article.

PII: S0002-9149(08)01495-1

doi: 10.1016/j.amjcard.2008.09.006

American Journal of Cardiology
Volume 102, Issue 9, Supplement , Pages 24J-28J , 3 November 2008

Article Tools

* Image Usage & Resolution